Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Davis

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
The British Journal of Dermatology|January 23, 2023
Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE studyJohannes S Kern, Eli Sprecher, Maria Florencia Fernandez, et al.
British Journal of Neurosurgery|February 24, 2022
Tumour treating fields in glioblastoma: is the treatment tolerable, effective, and practical in UK patients?Farouk Olubajo, Antonia Thorpe, Charles Davis, et al.
The Journal of Infectious Diseases|August 15, 2012
Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatmentRhea N Coler, Sylvie Bertholet, Samuel O Pine, et al.
The British Journal of Dermatology|September 19, 2025
Methodological concerns in the EASE study of Oleogel-S10 for epidermolysis bullosa: reply from authorsDédée F Murrell, Christine Bodemer, Anna L Bruckner, et al.
The British Journal of Dermatology|January 17, 2025
Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE studyDédée F Murrell, Christine Bodemer, Anna L Bruckner, et al.
Journal of Neuro-Oncology|February 15, 2016
Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform infrared spectroscopyJames R Hands, Graeme Clemens, Ryan Stables, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2017
Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized miceAlonso Heredia, Said Hassounah, Sandra Medina-Moreno, et al.
Pediatric Blood & Cancer|October 17, 2024
Pediatric patients with von Hippel-Lindau and hemangioblastomas treated successfully with belzutifanEmily Duan, Michael Robinson, Charles Davis, et al.
Journal of Biophotonics|January 8, 2014
Attenuated total reflection fourier transform infrared (ATR-FTIR) spectral discrimination of brain tumour severity from serum samplesJames R Hands, Konrad M Dorling, Peter Abel, et al.
The Journal of Infectious Diseases|January 26, 2012
Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trialHana M El Sahly, Charles Davis, Karen Kotloff, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
The British Journal of Dermatology|January 23, 2023
Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE studyJohannes S Kern, Eli Sprecher, Maria Florencia Fernandez, et al.
British Journal of Neurosurgery|February 24, 2022
Tumour treating fields in glioblastoma: is the treatment tolerable, effective, and practical in UK patients?Farouk Olubajo, Antonia Thorpe, Charles Davis, et al.
The Journal of Infectious Diseases|August 15, 2012
Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatmentRhea N Coler, Sylvie Bertholet, Samuel O Pine, et al.
The British Journal of Dermatology|September 19, 2025
Methodological concerns in the EASE study of Oleogel-S10 for epidermolysis bullosa: reply from authorsDédée F Murrell, Christine Bodemer, Anna L Bruckner, et al.
The British Journal of Dermatology|January 17, 2025
Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE studyDédée F Murrell, Christine Bodemer, Anna L Bruckner, et al.
Journal of Neuro-Oncology|February 15, 2016
Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform infrared spectroscopyJames R Hands, Graeme Clemens, Ryan Stables, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2017
Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized miceAlonso Heredia, Said Hassounah, Sandra Medina-Moreno, et al.
Pediatric Blood & Cancer|October 17, 2024
Pediatric patients with von Hippel-Lindau and hemangioblastomas treated successfully with belzutifanEmily Duan, Michael Robinson, Charles Davis, et al.
Journal of Biophotonics|January 8, 2014
Attenuated total reflection fourier transform infrared (ATR-FTIR) spectral discrimination of brain tumour severity from serum samplesJames R Hands, Konrad M Dorling, Peter Abel, et al.
The Journal of Infectious Diseases|January 26, 2012
Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trialHana M El Sahly, Charles Davis, Karen Kotloff, et al.
Pageof 11